Risk of relapse after vedolizumab withdrawal in Inflammatory Bowel Disease for patients in histological remission

被引：0
|
作者：
Blad, W. [1 ]
Whitley, L. [1 ]
Harrow, P. [1 ]
机构：
[1] Univ Coll London Hosp, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P808
引用
收藏
页码：942 / 942
页数：1
相关论文
共 50 条
  • [41] Care of inflammatory bowel disease patients in remission
    Subramanian, Charumathi Raghu
    Triadafilopoulos, George
    GASTROENTEROLOGY REPORT, 2016, 4 (04): : 261 - 271
  • [42] Withdrawal of thiopurines in Inflammatory Bowel Disease patients in stable remission: a prospective, multicentre cohort study
    Savelkoul, E.
    Mahmoud, R.
    De Jong, D.
    Van Dop, W.
    Romkens, T.
    Nissen, L.
    Mahmmod, N.
    Van Boeckel, P.
    Lutgens, M.
    Mares, W.
    Epping, L.
    Minderhoud, I.
    Jansen, J.
    Gisbertz, I.
    Boekema, P.
    De Koning, D.
    Horjus, C.
    Jharap, B.
    Oldenburg, B.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I335 - I335
  • [43] Withdrawal of thiopurines in Inflammatory Bowel Disease patients in stable remission: a prospective, multicentre cohort study
    Savelkoul, E.
    Mahmoud, R.
    De Jong, D.
    Van Dop, W.
    Romkens, T.
    Nissen, L.
    Mahmmod, N.
    Van Boeckel, P.
    Lutgens, M.
    Mares, W.
    Epping, L.
    Minderhoud, I.
    Jansen, J.
    Gisbertz, I.
    Boekema, P.
    De Koning, D.
    Horjus, C.
    Jharap, B.
    Oldenburg, B.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I335 - I335
  • [44] ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDY
    Mahmoud, Remi
    Savelkoul, Edo
    Mares, Wout
    Goetgebuer, Rogier
    Witteman, Ben
    de Koning, Daan
    Minderhoud, Itta M.
    van Tuyl, Sebastiaan
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Lutgens, Maurice
    Horje, Carmen S. Horjus Talabur
    Romkens, Tessa E. H.
    Akol-Simsek, Dilek
    Jansen, Jeroen M.
    Colombel, Jean Frederic
    Hoentjen, Frank
    Jharap, Bindia
    Oldenburg, Bas
    GASTROENTEROLOGY, 2022, 162 (07) : S809 - S809
  • [45] WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
    Savelkoul, Edo
    Mahmoud, Remi
    De Jong, Dirk J.
    van Dop, Willemijm A.
    Romkens, Tessa E. H.
    Nissen, Loes H.
    Mahmmod, Nofel
    van Boeckel, Petra G.
    Lutgens, Maurice
    Mares, Wont
    Epping, Ludger
    Minderhoud, Itta M.
    Jansen, Jeoren M.
    Gisbertz, Ingrid A.
    Boekema, Paul
    de Koning, Daan
    Horje, Carmen S. Horjus Talabur
    Jharap, Bindia
    Oldenburg, Bas
    Hoentjen, Frank
    GASTROENTEROLOGY, 2022, 162 (07) : S987 - S987
  • [46] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [47] Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
    Treton, Xavier
    Bouhnik, Yoram
    Mary, Jean-Yves
    Colombel, Jean-Frederic
    Duclos, Bernard
    Soule, Jean-Claude
    Lerebours, Eric
    Cosnes, Jacques
    Lemann, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (01) : 80 - 85
  • [48] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
  • [49] Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy
    Ungaro, Ryan
    Jossen, Jacqueline
    Phan, Becky
    Chefitz, Ezra
    Jain, Anjali
    Naik, Snehal
    Dubinsky, Marla
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S7 - S7
  • [50] Exercise Decreases Risk of Future Active Disease in Patients with Inflammatory Bowel Disease in Remission
    Jones, Patricia D.
    Kappelman, Michael D.
    Martin, Christopher F.
    Chen, Wenli
    Sandler, Robert S.
    Long, Millie D.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1063 - 1071
12345